Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 May;150(5):1595–1605.

Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.

R Dolcetti 1, R Giardini 1, C Doglioni 1, R Cariati 1, F Pomponi 1, C D'Orazi 1, S Rao 1, A I Lazarovits 1, E C Butcher 1, M Boiocchi 1
PMCID: PMC1858193  PMID: 9137086

Abstract

We have previously shown that the in vivo coordinated expression of individual alpha 4 and beta 7 integrin chains correlated with the leukemic potential displayed by cell lines derived from murine lymphoblastic T-cell lymphomas (T-LBLs) when transplanted subcutaneously into syngeneic AKR mice. In the present study, by using immunofluorescence and immunocytochemical analyses, we have confirmed that the in vivo up-regulation of the alpha 4 beta 7 heterodimeric complex is associated with the leukemic behavior of AKR T-LBLs. In addition, when compared with the parental, highly leukemic NQ22 cells, the variant cell line NQ22V exhibited a reduced leukemic potential that was invariably associated with a delayed alpha 4 beta 7 up-regulation in vivo Moreover, the leukemic cell line SJ-1, derived from a spontaneous T-LBL of the SJL strain, also displayed high levels of alpha 4 beta 7 expression with a pattern of tissue distribution similar to that of NQ22 cells from leukemic AKR animals. Of note, in most of the tissues involved by murine T-LBL dissemination, and particularly in liver, kidney, and lung, alpha 4 beta 7-positive leukemic cells were always located around strongly VCAM-1-positive vascular spaces. These findings are consistent with a possible role of alpha 4 beta 7/VCAM-1 interactions in the extravasation and, consequently, in the leukemic dissemination of murine T-LBL cells. Immunocytochemical analysis carried out in 11 human T-LBLs showed that pathological lymph nodes from all 7 cases with bone marrow infiltration at presentation carried alpha 4 beta 7-positive cells, whereas all 4 aleukemic T-LBLs were repeatedly alpha 4 beta 7 negative, also in metachronous lesions. These findings suggest that alpha 4 beta 7-positive human T-LBLs may represent a distinct clinicopathological entity. In addition, alpha 4 beta 7 expression was significantly more prevalent in younger patients (< 11 years; P = 0.02), further supporting such a hypothesis. Moreover, as in murine T-LBLs, the pattern of alpha 4 beta 7 positivity in involved lymph nodes was mainly focal, whereas nearly all neoplastic cells infiltrating bone marrow expressed this integrin, suggesting a possible role for alpha 4 beta 7 in the leukemic dissemination also of human T-LBLs.

Full text

PDF
1601

Images in this article

1599Figure 2
on p.1599
1600Figure 3
on p.1600
1602Figure 5
on p.1602

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alon R., Kassner P. D., Carr M. W., Finger E. B., Hemler M. E., Springer T. A. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol. 1995 Mar;128(6):1243–1253. doi: 10.1083/jcb.128.6.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berlin C., Bargatze R. F., Campbell J. J., von Andrian U. H., Szabo M. C., Hasslen S. R., Nelson R. D., Berg E. L., Erlandsen S. L., Butcher E. C. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 1995 Feb 10;80(3):413–422. doi: 10.1016/0092-8674(95)90491-3. [DOI] [PubMed] [Google Scholar]
  3. Berlin C., Berg E. L., Briskin M. J., Andrew D. P., Kilshaw P. J., Holzmann B., Weissman I. L., Hamann A., Butcher E. C. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell. 1993 Jul 16;74(1):185–195. doi: 10.1016/0092-8674(93)90305-a. [DOI] [PubMed] [Google Scholar]
  4. Bernard A., Boumsell L., Reinherz E. L., Nadler L. M., Ritz J., Coppin H., Richard Y., Valensi F., Dausset J., Flandrin G. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood. 1981 Jun;57(6):1105–1110. [PubMed] [Google Scholar]
  5. Bradstock K., Makrynikola V., Bianchi A., Byth K. Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts. Blood. 1993 Dec 1;82(11):3437–3444. [PubMed] [Google Scholar]
  6. Briskin M. J., McEvoy L. M., Butcher E. C. MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature. 1993 Jun 3;363(6428):461–464. doi: 10.1038/363461a0. [DOI] [PubMed] [Google Scholar]
  7. Chan B. M., Elices M. J., Murphy E., Hemler M. E. Adhesion to vascular cell adhesion molecule 1 and fibronectin. Comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B cell line JY. J Biol Chem. 1992 Apr 25;267(12):8366–8370. [PubMed] [Google Scholar]
  8. Dedhar S. Integrin mediated signal transduction in oncogenesis: an overview. Cancer Metastasis Rev. 1995 Sep;14(3):165–172. doi: 10.1007/BF00690289. [DOI] [PubMed] [Google Scholar]
  9. Dolcetti R., Carbone A., Barlati S., Maestro R., Rizzo S., Sonego F., Feriotto G., Bellotti D., Boiocchi M. Establishment and characterization of a leukemic murine cell line derived from MCF 247 MuLV-induced T-cell lymphoma. Int J Cancer. 1990 May 15;45(5):928–934. doi: 10.1002/ijc.2910450525. [DOI] [PubMed] [Google Scholar]
  10. Dolcetti R., Frisan T., Palmieri G., Rizzo S., Maestro R., Santoni A., Boiocchi M. In vivo phenotypic characteristics of AKR T-cell lymphomas with different leukemic potential: possible role of alpha 4 beta 7 integrin in the progression towards the leukemic phenotype. Int J Cancer. 1994 Feb 15;56(4):560–567. doi: 10.1002/ijc.2910560416. [DOI] [PubMed] [Google Scholar]
  11. Franks C. R., Bishop D., Balkwill F. R., Oliver R. T., Spector W. G. Growth of acute myeloid leukaemia as discrete subcutaneous tumours in immune-deprived mice. Br J Cancer. 1977 May;35(5):697–700. doi: 10.1038/bjc.1977.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gouttefangeas C., Bensussan A., Boumsell L. Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemia. Blood. 1990 Feb 15;75(4):931–934. [PubMed] [Google Scholar]
  13. Hamann A., Andrew D. P., Jablonski-Westrich D., Holzmann B., Butcher E. C. Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol. 1994 Apr 1;152(7):3282–3293. [PubMed] [Google Scholar]
  14. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  15. Head D. R., Behm F. G. Acute lymphoblastic leukemia and the lymphoblastic lymphomas of childhood. Semin Diagn Pathol. 1995 Nov;12(4):325–334. [PubMed] [Google Scholar]
  16. Holzmann B., McIntyre B. W., Weissman I. L. Identification of a murine Peyer's patch--specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4 alpha. Cell. 1989 Jan 13;56(1):37–46. doi: 10.1016/0092-8674(89)90981-1. [DOI] [PubMed] [Google Scholar]
  17. Juneja H. S., Rajaraman S., Gay R. E., Gay S., Schmalsteig F. C. Characterization of heterotypic adherence between transformed human lymphoblastic cells and marrow stromal cells: VCAM-1 is a ligand for one of the leukemia cell adhesion proteins. Exp Hematol. 1992 Dec;20(11):1263–1270. [PubMed] [Google Scholar]
  18. Juneja H. S., Schmalsteig F. C., Lee S., Chen J. Vascular cell adhesion molecule-1 and VLA-4 are obligatory adhesion proteins in the heterotypic adherence between human leukemia/lymphoma cells and marrow stromal cells. Exp Hematol. 1993 Mar;21(3):444–450. [PubMed] [Google Scholar]
  19. Kaneko Y., Frizzera G., Maseki N., Sakurai M., Komada Y., Sakurai M., Hiyoshi Y., Nakadate H., Takeda T. A novel translocation, t(9;17)(q34;q23), in aggressive childhood lymphoblastic lymphoma. Leukemia. 1988 Nov;2(11):745–748. [PubMed] [Google Scholar]
  20. Kaneko Y., Frizzera G., Shikano T., Kobayashi H., Maseki N., Sakurai M. Chromosomal and immunophenotypic patterns in T cell acute lymphoblastic leukemia (T ALL) and lymphoblastic lymphoma (LBL). Leukemia. 1989 Dec;3(12):886–892. [PubMed] [Google Scholar]
  21. Kilshaw P. J., Murant S. J. A new surface antigen on intraepithelial lymphocytes in the intestine. Eur J Immunol. 1990 Oct;20(10):2201–2207. doi: 10.1002/eji.1830201008. [DOI] [PubMed] [Google Scholar]
  22. Kilshaw P. J., Murant S. J. Expression and regulation of beta 7(beta p) integrins on mouse lymphocytes: relevance to the mucosal immune system. Eur J Immunol. 1991 Oct;21(10):2591–2597. doi: 10.1002/eji.1830211041. [DOI] [PubMed] [Google Scholar]
  23. Lazarovits A. I., Moscicki R. A., Kurnick J. T., Camerini D., Bhan A. K., Baird L. G., Erikson M., Colvin R. B. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen. J Immunol. 1984 Oct;133(4):1857–1862. [PubMed] [Google Scholar]
  24. Lefrançois L., Barrett T. A., Havran W. L., Puddington L. Developmental expression of the alpha IEL beta 7 integrin on T cell receptor gamma delta and T cell receptor alpha beta T cells. Eur J Immunol. 1994 Mar;24(3):635–640. doi: 10.1002/eji.1830240322. [DOI] [PubMed] [Google Scholar]
  25. Lobb R. R., Hemler M. E. The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest. 1994 Nov;94(5):1722–1728. doi: 10.1172/JCI117519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Machado E. A., Lozzio B. B., Lozzio C. B., Lair S. V., Aggio M. C. Development of myelosarcomas from human myelogenous leukemia cells transplanted in athymic mice. Cancer Res. 1977 Nov;37(11):3995–4002. [PubMed] [Google Scholar]
  27. Matsumoto K., Ziober B. L., Yao C. C., Kramer R. H. Growth factor regulation of integrin-mediated cell motility. Cancer Metastasis Rev. 1995 Sep;14(3):205–217. doi: 10.1007/BF00690292. [DOI] [PubMed] [Google Scholar]
  28. Miyoshi I., Ota T., Hiraki S., Sumida M., Tanaka T., Kimura I. Serial transplantation of a human T-cell acute lymphoblastic leukaemia line into nude mice. Br J Cancer. 1981 Jul;44(1):124–126. doi: 10.1038/bjc.1981.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Murphy S. B. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980 Sep;7(3):332–339. [PubMed] [Google Scholar]
  30. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989 Dec 22;59(6):1203–1211. doi: 10.1016/0092-8674(89)90775-7. [DOI] [PubMed] [Google Scholar]
  31. Picozzi V. J., Jr, Coleman C. N. Lymphoblastic lymphoma. Semin Oncol. 1990 Feb;17(1):96–103. [PubMed] [Google Scholar]
  32. Rice G. E., Munro J. M., Bevilacqua M. P. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J Exp Med. 1990 Apr 1;171(4):1369–1374. doi: 10.1084/jem.171.4.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rüegg C., Postigo A. A., Sikorski E. E., Butcher E. C., Pytela R., Erle D. J. Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering. J Cell Biol. 1992 Apr;117(1):179–189. doi: 10.1083/jcb.117.1.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schweighoffer T., Tanaka Y., Tidswell M., Erle D. J., Horgan K. J., Luce G. E., Lazarovits A. I., Buck D., Shaw S. Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism. J Immunol. 1993 Jul 15;151(2):717–729. [PubMed] [Google Scholar]
  35. Shikano T., Arioka H., Kobayashi R., Naito H., Ishikawa Y., Nakadate H., Hatae Y., Takeda T. Acute lymphoblastic leukemia and non-Hodgkin's lymphoma with mediastinal mass--a study of 23 children; different disorders or different stages? Leuk Lymphoma. 1994 Mar;13(1-2):161–167. doi: 10.3109/10428199409051667. [DOI] [PubMed] [Google Scholar]
  36. Stansfeld A. G., Diebold J., Noel H., Kapanci Y., Rilke F., Kelényi G., Sundstrom C., Lennert K., van Unnik J. A., Mioduszewska O. Updated Kiel classification for lymphomas. Lancet. 1988 Feb 6;1(8580):292–293. doi: 10.1016/s0140-6736(88)90367-4. [DOI] [PubMed] [Google Scholar]
  37. Watanabe S., Shimosato Y., Kameya T., Kuroki M., Kitahara T., Minato K., Shimoyama M. Leukemic distribution of a human acute lymphocytic leukemia cell line (Ichikawa strain) in nude mice conditioned with whole-body irradiation. Cancer Res. 1978 Oct;38(10):3494–3498. [PubMed] [Google Scholar]
  38. Weiss L. M., Bindl J. M., Picozzi V. J., Link M. P., Warnke R. A. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood. 1986 Feb;67(2):474–478. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES